76 related articles for article (PubMed ID: 16536999)
21. Preclinical evaluation of the novel hypoxic marker 99mTc-HL91 (Prognox) in murine and xenograft systems in vivo.
Honess DJ; Hill SA; Collingridge DR; Edwards B; Brauers G; Powell NA; Chaplin DJ
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):731-5. PubMed ID: 9845086
[TBL] [Abstract][Full Text] [Related]
22. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
Kostakoglu L; Uysal U; Ozyar E; Hayran M; Uzal D; Demirkazïk FB; Kars A; Atahan L; Bekdik CF
J Nucl Med; 1997 Jul; 38(7):1009-14. PubMed ID: 9225780
[TBL] [Abstract][Full Text] [Related]
23. Hypoxic imaging with 99mTc-HL91 single photon emission computed tomography in advanced nonsmall cell lung cancer.
Li L; Yu JM; Xing LG; Yang GR; Sun XD; Xu J; Zhu H; Yue JB
Chin Med J (Engl); 2006 Sep; 119(17):1477-80. PubMed ID: 16989751
[No Abstract] [Full Text] [Related]
24. [The study of 99mTc-N(NOEt)2 imaging in experimental nasopharyngeal carcinoma mice models].
Wang Y; Cao W; Xie G; Sun Y; Yang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Oct; 21(20):950-2. PubMed ID: 18254330
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of Tc-99m HL91 in tumor hypoxia: in vitro cell culture and in vivo tumor model.
Lee BF; Chiu NT; Hsia CC; Shen LH
Kaohsiung J Med Sci; 2008 Sep; 24(9):461-72. PubMed ID: 19073378
[TBL] [Abstract][Full Text] [Related]
26. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison between technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and magnetic resonance imaging.
Tai CJ; Shiau YC; Tsai MH; Wang JJ; Ho ST; Kao CH
Neoplasma; 2002; 49(4):251-4. PubMed ID: 12382024
[TBL] [Abstract][Full Text] [Related]
27. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison between technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography.
Sun SS; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2001; 21(2B):1307-10. PubMed ID: 11396204
[TBL] [Abstract][Full Text] [Related]
28. Comparison of technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography to detect recurrent or residual nasopharyngeal carcinomas after radiotherapy.
Shiau YC; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2001; 21(3C):2213-7. PubMed ID: 11501849
[TBL] [Abstract][Full Text] [Related]
29. [Biodistribution of hypoxic marker, 99mTc-HL91 (4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime)].
Suzuki T; Nakamura K; Kawase T; Kubo A
Kaku Igaku; 2001 Jul; 38(4):333-41. PubMed ID: 11530380
[TBL] [Abstract][Full Text] [Related]
30. [Primary exploration of individual biological boosting target volume for locally advanced nasopharyngeal carcinoma].
Wen G; Huang XB; Zhang WD; Lin XP; He ZC; Xia YF
Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(45):3207-10. PubMed ID: 23328468
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.
Yip C; Cook GJ; Wee J; Fong KW; Tan T; Goh V
Chin Clin Oncol; 2016 Apr; 5(2):24. PubMed ID: 27121884
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of undifferentiated carcinoma of nasopharyngeal type with thallium-201 and technetium-99m MIBI SPECT.
Sobic-Saranovic DP; Pendjer IP; Kozarevic NDj; Artiko VM; Mikic AA; Obradovic VB
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):405-11. PubMed ID: 17765766
[TBL] [Abstract][Full Text] [Related]
33. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
34. 99mTc-HL91. Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent.
Okada RD; Johnson G; Nguyen KN; Edwards B; Archer CM; Kelly JD
Circulation; 1997 Apr; 95(7):1892-9. PubMed ID: 9107178
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow.
Tatsumi M; Yutani K; Kusuoka H; Nishimura T
Eur J Nucl Med; 1999 Feb; 26(2):91-4. PubMed ID: 9933342
[TBL] [Abstract][Full Text] [Related]
36. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
37. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study.
Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S
Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275
[TBL] [Abstract][Full Text] [Related]
38. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
Kostakoglu L; Uysal U; Ozyar E; Elahi N; Hayran M; Uzal D; Demirkazik FB; Kars A; Uğur O; Atahan L; Bekdik CF
J Nucl Med; 1996 Dec; 37(12):1956-62. PubMed ID: 8970513
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium.
Imahashi K; Morishita K; Kusuoka H; Yamamichi Y; Hasegawa S; Hashimoto K; Shirakami Y; Kato-Azuma M; Nishimura T
J Nucl Med; 2000 Jun; 41(6):1102-7. PubMed ID: 10855642
[TBL] [Abstract][Full Text] [Related]
40. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.
Ma BB; King A; Lo YM; Yau YY; Zee B; Hui EP; Leung SF; Mo F; Kam MK; Ahuja A; Kwan WH; Chan AT
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):714-20. PubMed ID: 17011447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
